Trials / Completed
CompletedNCT02419677
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- The First People's Hospital of Changzhou · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with colorectal cancer liver metastases (CRCLM).
Detailed description
The primary objective is to evaluate whether RFA followed by CIK transfusion can prolong survival of patients with resectable CRCLM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency ablation | Radiofrequency ablation is performed percutaneously under CT/US guidance. |
| BIOLOGICAL | Cytokine-induced killer cells | The patients received autologous cytokine-induced killer cells transfusion one week after RFA treatment. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2015-04-17
- Last updated
- 2015-04-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02419677. Inclusion in this directory is not an endorsement.